Results from independent studies included samples of total 1102 patients with eight types of cancer, including NSCLC, multiple myeloma (MM), gastric adenocarcinoma (GA), and hepatocellular carcinoma (HCC), revealing a strong association between elevated levels of sPD-L1 and poor OS in all analyzed types of cancer. Here, SPDL1 is linked to hepatocellular carcinoma.